Vivo Bio Tech Limited (BOM:511509)

Vivo Bio Tech Statistics

Total Valuation

Vivo Bio Tech has a market cap or net worth of INR 537.90 million. The enterprise value is 1.09 billion.

Market Cap	537.90M
Enterprise Value	1.09B

Important Dates

The next estimated earnings date is Tuesday, May 19, 2026.

Earnings Date	May 19, 2026
Ex-Dividend Date	n/a

Share Statistics

Vivo Bio Tech has 22.19 million shares outstanding. The number of shares has increased by 15.62% in one year.

Current Share Class	22.19M
Shares Outstanding	22.19M
Shares Change (YoY)	+15.62%
Shares Change (QoQ)	+15.47%
Owned by Insiders (%)	12.89%
Owned by Institutions (%)	n/a
Float	6.07M

Valuation Ratios

The trailing PE ratio is 10.38.

PE Ratio	10.38
Forward PE	n/a
PS Ratio	1.05
PB Ratio	0.56
P/TBV Ratio	0.72
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	24.13
EV / Sales	2.12
EV / EBITDA	6.05
EV / EBIT	9.65
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.58
Debt / EBITDA	3.14
Debt / FCF	n/a
Interest Coverage	1.87

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	5.79%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	6.27%
Revenue Per Employee	2.96M
Profits Per Employee	259,569
Employee Count	174
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Vivo Bio Tech has paid 12.84 million in taxes.

Income Tax	12.84M
Effective Tax Rate	22.13%

Stock Price Statistics

The stock price has decreased by -34.40% in the last 52 weeks. The beta is -0.03, so Vivo Bio Tech's price volatility has been lower than the market average.

Beta (5Y)	-0.03
52-Week Price Change	-34.40%
50-Day Moving Average	26.64
200-Day Moving Average	32.64
Relative Strength Index (RSI)	45.81
Average Volume (20 Days)	35,472

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vivo Bio Tech had revenue of INR 514.24 million and earned 45.17 million in profits. Earnings per share was 2.34.

Revenue	514.24M
Gross Profit	445.78M
Operating Income	112.91M
Pretax Income	58.00M
Net Income	45.17M
EBITDA	180.20M
EBIT	112.91M
Earnings Per Share (EPS)	2.34

Balance Sheet

The company has 13.32 million in cash and 565.32 million in debt, with a net cash position of -551.99 million or -24.88 per share.

Cash & Cash Equivalents	13.32M
Total Debt	565.32M
Net Cash	-551.99M
Net Cash Per Share	-24.88
Equity (Book Value)	967.69M
Book Value Per Share	50.13
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	67.29M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 86.69%, with operating and profit margins of 21.96% and 8.78%.

Gross Margin	86.69%
Operating Margin	21.96%
Pretax Margin	11.28%
Profit Margin	8.78%
EBITDA Margin	35.04%
EBIT Margin	21.96%
FCF Margin	n/a

Dividends & Yields

Vivo Bio Tech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.62%
Shareholder Yield	-15.62%
Earnings Yield	8.40%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 7, 2005. It was a reverse split with a ratio of 0.1.

Last Split Date	Oct 7, 2005
Split Type	Reverse
Split Ratio	0.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2